Cargando…
Management of refractory chronic pain in sickle cell disease with intrathecal drug delivery system
Autores principales: | Mendes, Plinio Duarte, Chequer, Karen Miranda, Thomaz, Clara Martins Azevedo Eyer, Assunção, Gustavo Marcio Silvino, Augusto, Felipe Duarte, Fonseca Filho, Gilberto de Almeida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499565/ https://www.ncbi.nlm.nih.gov/pubmed/34593369 http://dx.doi.org/10.1016/j.htct.2021.07.005 |
Ejemplares similares
-
Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction
por: Nakatani, Yuko, et al.
Publicado: (2017) -
Primary Repair of Esophageal Perforation Following Anterior Cervical Fusion
por: Dantas, Fernando Luiz R, et al.
Publicado: (2020) -
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
por: McDowell, Gladstone C., et al.
Publicado: (2016) -
Emergent Radiotherapy for Leukemia-Induced Cranial Neuropathies Refractory to Intrathecal Therapy
por: Patel, Nirav, et al.
Publicado: (2021) -
A new trigger for an old problem-neurogenic pulmonary edema related to intrathecal chemotherapy with pemetrexed
por: Forgiarini, Elaine Aparecida, et al.
Publicado: (2023)